Survivin may be a Key Target for Oxaliplatin.
10.3393/jksc.2010.26.4.239
- Author:
Moo Jun BAEK
1
Author Information
1. Department of Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea. ssurge@sch.ac.kr
- Publication Type:Editorial
- MeSH:
Organoplatinum Compounds
- From:Journal of the Korean Society of Coloproctology
2010;26(4):239-239
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.